Geoffrey A. Kerchner

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 12 papers. Top paper: “Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial”.

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

The Lancet Neurology(2025)10.1016/s1474-4422(25)00024-9

N/A

1.2DataRank · unranked

41 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +62 more

Sustained effect of prasinezumab on Parkinson’s disease motor progression in the open-label extension of the PASADENA trial

Nature Medicine(2024)10.1038/s41591-024-03270-6

N/A

0.908DataRank · unranked

51 citations

Annabelle Monnet, Adriana Reyes, Benjamin Ribba, Hanno Svoboda, Thomas Kustermann +17 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial

medRxiv(2024)10.1101/2024.10.29.24316289

N/A

0.351DataRank · unranked

6 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +63 more

Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction

Research Square(2024)10.21203/rs.3.rs-4980210/v1

N/A

0.165DataRank · unranked

2 citations

Jacob Umans, Michelle S. Swarovski, Paras S. Minhas, Øivind Midttun, Arve Ulvik +28 more

Aromatic L-Amino Acid Decarboxylase is a novel fluid biomarker of Parkinson’s disease

medRxiv(2022)10.1101/2022.11.09.22282149

N/A

0.165DataRank · unranked

2 citations

Benoit Lehallier, Pardis Zarifkar, Patricia Morán Losada, Sephira G. Ryman, Maya Yutsis +12 more

Parkinson’s disease is characterized by vitamin B6-dependent inflammatory kynurenine pathway dysfunction

npj Parkinson s Disease(2025)10.1038/s41531-025-00964-7

N/A

0DataRank · unranked

16 citations

Jacob Umans, Michelle S. Swarovski, Paras S. Minhas, Jaime Mendiola, Øivind Midttun +29 more

Substantia Nigra Volume Dissociates Bradykinesia and Rigidity from Tremor in Parkinson’s Disease: A 7 Tesla Imaging Study

Journal of Parkinson s Disease(2020)10.3233/jpd-191890

N/A

0DataRank · unranked

33 citations

Matthew A. I. Ua Cruadhlaoich, Laura F. Santoso, Jeffrey D. Bernstein, Tian Liu, Yi Wang +4 more

Synergistic effects of APOE ε4 and Alzheimer’s pathology on the neural correlates of episodic remembering in cognitively unimpaired older adults

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.06.20.660774

N/A

0DataRank · unranked

0 citations

Jintao Sheng, Edward N. Wilson, America Romero, Jennifer Park, Gayle K. Deutsch +7 more

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Nature Medicine(2021)10.1038/s41591-021-01369-8

N/A

0DataRank · unranked

365 citations

Martin R. Farlow, Eric McDade, David B. Clifford, Guoqiao Wang, Jorge J. Llibre‐Guerra +61 more

Comprehensive proteomics of CSF, plasma, and urine identify DDC and other biomarkers of early Parkinson’s disease

Acta Neuropathologica(2024)10.1007/s00401-024-02706-0

N/A

0DataRank · unranked

96 citations

Benoit Lehallier, Pardis Zarifkar, Patricia Morán Losada, Marian Shahid, Daniel Western +16 more

Plasma Aβ 42 /Aβ 40 is sensitive to early cerebral amyloid accumulation and predicts risk of cognitive decline across the Alzheimer's disease spectrum

Alzheimer s & Dementia(2024)10.1002/alz.14442

N/A

0DataRank · unranked

37 citations

Christina B. Young, Hillary Vossler, Javier Ramos Benitez, Karly Alex Cody, Jaime Mendiola +30 more

Plasma pTau181 Reveals a Pathological Signature that Predicts Cognitive Outcomes in Lewy Body Disease

Annals of Neurology(2024)10.1002/ana.27003

N/A

0DataRank · unranked

11 citations

Christina B. Young, Marian Shahid, Alena Smith, Edward N. Wilson, Javier Ramos Benitez +13 more